{"id":8244,"date":"2023-09-12T16:43:04","date_gmt":"2023-09-12T20:43:04","guid":{"rendered":"https:\/\/vaccines.phila.gov\/?post_type=lsvr_notice&#038;p=8244"},"modified":"2024-09-11T15:50:58","modified_gmt":"2024-09-11T19:50:58","slug":"new-vaccine-product-available-for-vfc-vfaar","status":"publish","type":"post","link":"https:\/\/vaccines.phila.gov\/index.php\/new-vaccine-product-available-for-vfc-vfaar\/","title":{"rendered":"New Vaccine Product Available for VFC\/VFAAR"},"content":{"rendered":"\n<p class=\"has-large-font-size\"><strong>New Vaccine Product Available for VFC\/VFAAR<\/strong><\/p>\n\n\n\n<p><strong>A one-vial presentation of Menveo (MenACYW-135) is now available through the Philadelphia\u00a0VFC\u00a0&amp;\u00a0VFAAR\u00a0programs.<\/strong>\u00a0This presentation does not require reconstitution. The Prescribing Information now describes both presentations of Menveo: the current two-vial presentation\u00a0and\u00a0a\u00a0new\u00a0one-vial presentation.\u00a0<\/p>\n\n\n\n<p class=\"has-medium-font-size\"><strong>One-vial Presentation (NEW)\u00a0<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>NDC: 58160-0827-30&nbsp;<\/li>\n\n\n\n<li>For use in individuals 10 years through 55 years of age.&nbsp;<\/li>\n\n\n\n<li>The one-vial presentation contains Menveo in a single vial with a pink cap&nbsp;<\/li>\n\n\n\n<li>This presentation does not require reconstitution.&nbsp;<\/li>\n\n\n\n<li>Available to order for\u00a0VFC\u00a0and\u00a0VFAAR.\u00a0<\/li>\n<\/ul>\n\n\n\n<p class=\"has-medium-font-size\"><strong>Two-vial Presentation<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>NDC: 58160-0955-09<\/li>\n\n\n\n<li>For use in individuals with special medical conditions 2 months through 9 years of age going forward*<\/li>\n\n\n\n<li>The two-vial presentation includes a vial with a gray cap containing the MenCYW-135 liquid conjugate component&nbsp;and&nbsp;a vial with an orange cap containing the MenA lyophilized conjugate component. The contents of the vials must be combined to form Menveo prior to administration.&nbsp;<\/li>\n\n\n\n<li><strong>The two-vial presentation is no longer available through&nbsp;VFAAR.&nbsp;<\/strong><\/li>\n\n\n\n<li>Providers with existing supply of the Menveo 2-vial presentation on hand may continue to administer the vaccine to indicated\u00a0VFC-eligible patients aged 2 months \u2013 18 years of age. Do not initiate returns of the Menveo 2-vial presentation until the vaccine expires. The Philadelphia\u00a0VFC\u00a0Program will not process returns of unexpired Menveo 2-vial vaccine.<\/li>\n<\/ul>\n\n\n\n<p><em>*There is a limited supply of the two-vial presentation available through the\u00a0VFC\u00a0program. To ensure that vaccine is available for individuals 2 months of age through 9 years of age, plan to only use the two-vial presentation for individuals 2 months through 9 years of age. Order the one-vial presentation for individuals 10 years through 18 years of age.\u00a0<\/em><\/p>\n\n\n\n<p class=\"has-medium-font-size\"><strong>CPT\/CVX Codes<\/strong><\/p>\n\n\n\n<p><em>The CPT\u00a0and\u00a0CVX code for the\u00a0new\u00a0presentation is the same as the old presentation:<\/em>\u00a0\u00a0<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>CPT:&nbsp;<strong>90734<\/strong>&nbsp;<\/li>\n\n\n\n<li>CVX:\u00a0<strong>136<\/strong><\/li>\n<\/ul>\n\n\n\n<p class=\"has-medium-font-size\"><strong>Resources<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/gcc02.safelinks.protection.outlook.com\/?url=http%3A%2F%2Furl4461.phila.gov%2Fls%2Fclick%3Fupn%3DlzwH8cWYAT0ZUdyYH04X5KjF0BhHiu4IDzFaGMi60iNqZE6eyCm1DaJam4HfvvKeMrnU1AEnUjZT6iDwT5i0ACshI-2FJzOsiGxCLi9567AxI-3DskkU_0qfPRZcZQl691jsq1IFhw-2B5lSBHguV4qQwCMHa8wboYQpHK6t5rl-2BnllQSRsj8R4tGUo9FSjV9ncVJzriQ1la6lLgUiCWNpfVroDZYLxQovE1nz2bPHaMldpVNqAsf3FjPUGxfBekGuFHtroxWjVfWwFfAzjtQu7hbHQ3llkOwauZ0KrHRRJIheaA3RERvN6wB-2BhLkAwbw3j9VJKDxQ7dU53Ti0YL2XseqjInQbmY4jTZrpvGa8ia3wsYw74paP-2BNaI4ljgVRdxySg-2BAotgGtQZvPXPljHAii2UxCENhNYpIz41us5Q7rmTZkBawv2V2wdPew0qqcv09-2Fsj3GjZQaBFxTJ4f9aqiqYUUYvzMoZxysLQ3HBOc0WdHbCId3pcz-2FR7wq3Rp9s2O90oYKoF7ZWtS3ayp9cGyTCz9UszPEXrpdurKmmS4K7wUwxXlGCQYxuZl1lvIyZEA3RWAzW1YKVb7URVCIPGpH8Ef2uSjypJPnQ15ijPxjyJzDz0GE0Qynl0oxXw97sTvPLdLx90pQkRDvFQk46o2Lw8eFu0QU06YzkD9gFjmEoKF-2BQ9PMJ-2F9YVN0d2CLizS8gYjLs58RwBCOZ8VyFcCSBRzDy14mS9KtoRPeV6eXYk6hOPVnbdpCtDkkDw5iNe1uXna3OWPIchboHzAo4q28kWGH6uWlp5nTs4Dx73R855AyF-2BDgqykENYs4grCj3LKJ2w6ZVS0marGXBOxZ8qfKNhp1srtSJ6PevdAAqZDZcYEmx3wGfIkqTOaAivwMvQCac1ANuwc-2BBFJbFlL76cvcgCad7NV3K1x0-2BRWBlyIMjLjtqf4ryqnTd67nysjhXz-2BeA4I29ELiMV88zwCnElKjeWIDiUlbLcWcfqfdAWM3uB4rsFFLovgGNGSRrrZy9R5bHOBaM-2FSZnkuJqReADWOkk-2BKawa0CfwQAk1gw3QcvyPx9ns1a9IjECQkhlzIMvIwOebs4LG5-2F4-2FUtqz7SCBU2ohdd8dxYm-2FkFk8BIbw8atH6Pal-2BJDaNwFSWAIExx7ifAJg1Sq3v6TQ-3D-3D&amp;data=05%7C01%7Crishi.sharma%40phila.gov%7C65c01dfbede94579a15d08dbb2bed9d5%7C2046864f68ea497daf34a6629a6cd700%7C0%7C0%7C638300305008490210%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&amp;sdata=qkostsin55e%2BV55yq4LIkQF34b%2FqvXtlT%2BOTQhrC1Pw%3D&amp;reserved=0\" target=\"_blank\" rel=\"noreferrer noopener\">FDA: Menveo Information<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/gcc02.safelinks.protection.outlook.com\/?url=http%3A%2F%2Furl4461.phila.gov%2Fls%2Fclick%3Fupn%3DlzwH8cWYAT0ZUdyYH04X5L0WFl6o9b3G0t75D9954ZOWZa9e84S8ZepRRW0n5ColJ6C0z-2FdqlridavChNitIJ3B-2BTRGPgZWAC6OD83YJW9g-3DFrbH_0qfPRZcZQl691jsq1IFhw-2B5lSBHguV4qQwCMHa8wboYQpHK6t5rl-2BnllQSRsj8R4tGUo9FSjV9ncVJzriQ1la6lLgUiCWNpfVroDZYLxQovE1nz2bPHaMldpVNqAsf3FjPUGxfBekGuFHtroxWjVfWwFfAzjtQu7hbHQ3llkOwauZ0KrHRRJIheaA3RERvN6wB-2BhLkAwbw3j9VJKDxQ7dU53Ti0YL2XseqjInQbmY4jTZrpvGa8ia3wsYw74paP-2BNaI4ljgVRdxySg-2BAotgGtQZvPXPljHAii2UxCENhNYpIz41us5Q7rmTZkBawv2V2wdPew0qqcv09-2Fsj3GjZQaBFxTJ4f9aqiqYUUYvzMoZxysLQ3HBOc0WdHbCId3pcz-2FR7wq3Rp9s2O90oYKoF7ZWtS3ayp9cGyTCz9UszPEXrpdurKmmS4K7wUwxXlGCQYxuZl1lvIyZEA3RWAzW1YKVb7URVCIPGpH8Ef2uSjypJPnQ15ijPxjyJzDz0GE0Qynl0oxXw97sTvPLdLx90pQkRDvFQk46o2Lw8eFu0QU06YzkD9gFjmEoKF-2BQ9PMJ-2F9YVN0d2CLizS8gYjLs58RwBCOZ8VyFcCSBRzDy14mS9KtoRPeV6eXYk6hOPVnbdpCtDkkDw5iNe1uXna3OWPIchboHzAo4q28kWGH6uWlp5nTs4Dx73R855AyF-2BDgqykENYs4grCj3LKJ2w6ZVS0marGXBOxZ8qfKNhp1srtSJ6PevdAAqZDZcYEmx3wGfIkqTOaAivwMvQCac1ANuwc-2BBFJbFlL76cvcgCad7NV3K1x0-2BRWBlyIMjLjtqf4ryqnTd67nysjhXz-2BeA4I29ELiMV88zwCnElKjeWIDiUlbLcUixKgJacSLnFTcOkx3-2F7eLbOZTv6Vtvva6vBj1FEH9-2B-2F8fgEqg8CL-2BgoRuGEVPNdGJrAwq1KxyJfhdrb5vQt-2BYEpw6U429BaYPPHarMS-2BJt0zl9CNHFTqGCL-2FpGgtHJ0t39RVebyLpS9ZGTZnqBZd7nTdd-2BMyiRfkPFdDy6BXbcQ-3D-3D&amp;data=05%7C01%7Crishi.sharma%40phila.gov%7C65c01dfbede94579a15d08dbb2bed9d5%7C2046864f68ea497daf34a6629a6cd700%7C0%7C0%7C638300305008490210%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&amp;sdata=sWbx1W6Pppb4LbHuc7w0tdWC8yjRX2Ti%2F4HwrmbP3xc%3D&amp;reserved=0\" target=\"_blank\" rel=\"noreferrer noopener\">Immunize.org: Ask the Experts<\/a>&nbsp;<\/li>\n\n\n\n<li><a rel=\"noreferrer noopener\" href=\"https:\/\/gcc02.safelinks.protection.outlook.com\/?url=http%3A%2F%2Furl4461.phila.gov%2Fls%2Fclick%3Fupn%3DlzwH8cWYAT0ZUdyYH04X5L0WFl6o9b3G0t75D9954ZMhJwicuZd-2B-2FUm61dcgCK5rZmGNXjVNHHCbQad0loiAwaG5b2NQGilxE6hIJOVIIQU-3DFDuU_0qfPRZcZQl691jsq1IFhw-2B5lSBHguV4qQwCMHa8wboYQpHK6t5rl-2BnllQSRsj8R4tGUo9FSjV9ncVJzriQ1la6lLgUiCWNpfVroDZYLxQovE1nz2bPHaMldpVNqAsf3FjPUGxfBekGuFHtroxWjVfWwFfAzjtQu7hbHQ3llkOwauZ0KrHRRJIheaA3RERvN6wB-2BhLkAwbw3j9VJKDxQ7dU53Ti0YL2XseqjInQbmY4jTZrpvGa8ia3wsYw74paP-2BNaI4ljgVRdxySg-2BAotgGtQZvPXPljHAii2UxCENhNYpIz41us5Q7rmTZkBawv2V2wdPew0qqcv09-2Fsj3GjZQaBFxTJ4f9aqiqYUUYvzMoZxysLQ3HBOc0WdHbCId3pcz-2FR7wq3Rp9s2O90oYKoF7ZWtS3ayp9cGyTCz9UszPEXrpdurKmmS4K7wUwxXlGCQYxuZl1lvIyZEA3RWAzW1YKVb7URVCIPGpH8Ef2uSjypJPnQ15ijPxjyJzDz0GE0Qynl0oxXw97sTvPLdLx90pQkRDvFQk46o2Lw8eFu0QU06YzkD9gFjmEoKF-2BQ9PMJ-2F9YVN0d2CLizS8gYjLs58RwBCOZ8VyFcCSBRzDy14mS9KtoRPeV6eXYk6hOPVnbdpCtDkkDw5iNe1uXna3OWPIchboHzAo4q28kWGH6uWlp5nTs4Dx73R855AyF-2BDgqykENYs4grCj3LKJ2w6ZVS0marGXBOxZ8qfKNhp1srtSJ6PevdAAqZDZcYEmx3wGfIkqTOaAivwMvQCac1ANuwc-2BBFJbFlL76cvcgCad7NV3K1x0-2BRWBlyIMjLjtqf4ryqnTd67nysjhXz-2BeA4I29ELiMV88zwCnElKjeWIDiUlbLcXoqoQizSMsSJ9IrIWB682shFvdjzwZHYW0LhF67ysOWCmQ-2BqL88594e-2Bm4uzzyGo0JGeVTsxHUYwPtHYVx4EuiQDOh5uERrIBsRQ2O5NjLTGViDBjeZiaqXQ7R8lgU8jo1HTomz28-2BePGHD5BDjoOjgmZhJrL50IhQEm5A2JNCwQ-3D-3D&amp;data=05%7C01%7Crishi.sharma%40phila.gov%7C65c01dfbede94579a15d08dbb2bed9d5%7C2046864f68ea497daf34a6629a6cd700%7C0%7C0%7C638300305008490210%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&amp;sdata=D2Drs7R5VAOFyPGMLfnvsPRGURPuFMPJ9olLirF9LIM%3D&amp;reserved=0\" target=\"_blank\">VIS<\/a><\/li>\n<\/ul>\n\n\n\n<p><strong>Sites using the two-vial presentation of Menveo you can now order the one vial presentation.&nbsp;<\/strong>Please make sure the Menveo, one-vial presentation, is added to your EHR before ordering. If you have any issues ordering, please reach out to our coordinators:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Victor Obeck\u00a0<\/strong>(VFC): <a href=\"mailto:victor.obeck@phila.gov?subject=&amp;body=\">Victor.Obeck@phila.gov\u00a0<\/a><\/li>\n\n\n\n<li><strong>Kenya Mack\u00a0<\/strong>(VFAAR): <a href=\"mailto:kenya.mack@phila.gov?subject=&amp;body=\">Kenya.Mack@phila.gov<\/a><\/li>\n<\/ul>\n\n\n\n<p><strong>Thank you for keeping Philadelphia safe\u00a0and\u00a0healthy. If you have any questions, please email\u00a0<\/strong><a href=\"mailto:vaccines@phila.gov?subject=&amp;body=\"><strong>vaccines@phila.gov<\/strong><\/a><strong>.<\/strong><\/p>\n\n\n\n<p>Please note, Menveo\u00a0and\u00a0Menquadfi are interchangeable. To change the formulation that your site orders, please complete the\u202f<a rel=\"noreferrer noopener\" href=\"https:\/\/gcc02.safelinks.protection.outlook.com\/?url=http%3A%2F%2Furl4461.phila.gov%2Fls%2Fclick%3Fupn%3DlzwH8cWYAT0ZUdyYH04X5Os0LhRh-2FAjCZ9Eo-2B-2BWLGj1woKrkxdvyO1sbH4RGx45N1T3K2I2osQJm3IUlFdEhm6dl-2BXshrH7YVB6EFpiiwTY-3DzhBX_0qfPRZcZQl691jsq1IFhw-2B5lSBHguV4qQwCMHa8wboYQpHK6t5rl-2BnllQSRsj8R4tGUo9FSjV9ncVJzriQ1la6lLgUiCWNpfVroDZYLxQovE1nz2bPHaMldpVNqAsf3FjPUGxfBekGuFHtroxWjVfWwFfAzjtQu7hbHQ3llkOwauZ0KrHRRJIheaA3RERvN6wB-2BhLkAwbw3j9VJKDxQ7dU53Ti0YL2XseqjInQbmY4jTZrpvGa8ia3wsYw74paP-2BNaI4ljgVRdxySg-2BAotgGtQZvPXPljHAii2UxCENhNYpIz41us5Q7rmTZkBawv2V2wdPew0qqcv09-2Fsj3GjZQaBFxTJ4f9aqiqYUUYvzMoZxysLQ3HBOc0WdHbCId3pcz-2FR7wq3Rp9s2O90oYKoF7ZWtS3ayp9cGyTCz9UszPEXrpdurKmmS4K7wUwxXlGCQYxuZl1lvIyZEA3RWAzW1YKVb7URVCIPGpH8Ef2uSjypJPnQ15ijPxjyJzDz0GE0Qynl0oxXw97sTvPLdLx90pQkRDvFQk46o2Lw8eFu0QU06YzkD9gFjmEoKF-2BQ9PMJ-2F9YVN0d2CLizS8gYjLs58RwBCOZ8VyFcCSBRzDy14mS9KtoRPeV6eXYk6hOPVnbdpCtDkkDw5iNe1uXna3OWPIchboHzAo4q28kWGH6uWlp5nTs4Dx73R855AyF-2BDgqykENYs4grCj3LKJ2w6ZVS0marGXBOxZ8qfKNhp1srtSJ6PevdAAqZDZcYEmx3wGfIkqTOaAivwMvQCac1ANuwc-2BBFJbFlL76cvcgCad7NV3K1x0-2BRWBlyIMjLjtqf4ryqnTd67nysjhXz-2BeA4I29ELiMV88zwCnElKjeWIDiUlbLcUIBOafKXzxW-2FrP0-2FqOnJs3cElgT1oVzP-2FsDGYWuhEU7IxoOTMBN7ah3r6QyDLPGfSwEBqXVkFwSrMBgRcVvT1AJkZ0TNN7bEa96Nqvi3vbIcRLSVT-2BtEnihm7aAzT-2FECIh9GpcBTTkkFJYP4RzmQWjXb1mjQY3UUQGUDI-2Bi0Dd8w-3D-3D&amp;data=05%7C01%7Crishi.sharma%40phila.gov%7C65c01dfbede94579a15d08dbb2bed9d5%7C2046864f68ea497daf34a6629a6cd700%7C0%7C0%7C638300305008490210%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&amp;sdata=Y%2BzvvdHs2%2B0epvu%2FtE%2FV6TRuDmMheeh4v2CrvqlarZQ%3D&amp;reserved=0\" target=\"_blank\">Change Request Form<\/a>. Our team will review your request\u00a0and\u00a0reply with next steps. We recommend that sites that are part of a system or are affiliated use the same vaccine presentations across sites to ensure continuity of care\u00a0and\u00a0help prevent administration errors.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>New Vaccine Product Available for VFC\/VFAAR A one-vial presentation of Menveo (MenACYW-135) is now available through the Philadelphia\u00a0VFC\u00a0&amp;\u00a0VFAAR\u00a0programs.\u00a0This presentation does not require reconstitution. The Prescribing Information now describes both presentations of Menveo: the current two-vial presentation\u00a0and\u00a0a\u00a0new\u00a0one-vial presentation.\u00a0 One-vial Presentation (NEW)\u00a0 Two-vial Presentation *There is a&#8230;<\/p>\n","protected":false},"author":22,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[138,139],"tags":[],"class_list":["post-8244","post","type-post","status-publish","format-standard","hentry","category-vfaar","category-vfc"],"_links":{"self":[{"href":"https:\/\/vaccines.phila.gov\/index.php\/wp-json\/wp\/v2\/posts\/8244","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vaccines.phila.gov\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vaccines.phila.gov\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vaccines.phila.gov\/index.php\/wp-json\/wp\/v2\/users\/22"}],"replies":[{"embeddable":true,"href":"https:\/\/vaccines.phila.gov\/index.php\/wp-json\/wp\/v2\/comments?post=8244"}],"version-history":[{"count":0,"href":"https:\/\/vaccines.phila.gov\/index.php\/wp-json\/wp\/v2\/posts\/8244\/revisions"}],"wp:attachment":[{"href":"https:\/\/vaccines.phila.gov\/index.php\/wp-json\/wp\/v2\/media?parent=8244"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vaccines.phila.gov\/index.php\/wp-json\/wp\/v2\/categories?post=8244"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vaccines.phila.gov\/index.php\/wp-json\/wp\/v2\/tags?post=8244"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}